Our lab previously described the functions of Oct4 and Sox2 in driving the de-differentiation of GBM cells into GSCs, highlighting the ability of Oct4/Sox2 to enhance tumorigenicity and tumor cell-mediated immune suppression [5,9]. The gene discussed is POU5F1; the disease is neoplasm.